Evergreening Withers in IndiaWhen India's Supreme Court ruled in April that Novartis AG's cancer drug Gleevec was not sufficiently innovative to merit a patent, public health advocates lauded the decision. They said that it would give more people access to needed drugs. Corporate Counsel, 1 week ago
Novartis India announces results for the quarter and year ended March 31, 2013
- Express Pharma, 1 week ago
|
269 images for novartis india | ||||
Stocks in news: DLF, Bharti Airtel, ONGC, Shriram EPCResults Today: DRL, Novartis India, Muthoot Finance, Pfizer, Reliance Infra, United Bank, Sun Pharma ADV, Bartronics, DCW, Dwarikesh Sugar, Elder Health, Elder Pharma, HT Media, Jindal Hotel, JSL Inds, Maharashtra Scooters, Mirc Elec, Munjal Auto, ... Moneycontrol.com, 1 week ago
Stocks in news: DLF, Jet Airways, Linde India
Moneycontrol.com, 1 week ago
|
Novartis India to organise BioCamp from July 8-10 in HyderabadNovartis India, a world leader in the research and development of products to protect and improve health and well-being, is organising three-day Novartis Biotechnology Leadership Camp (BioCamp) from July 8 to 10, 2013 in Hyderabad. BioCamp is a ... PharmaBiz, 1 week ago
Companies Look Overseas for Cheap Subjects
Spiegel Online, 1 week ago
Indian Shares Seen Largely Unchanged Before Data
RTTNews.com, 1 week ago
Patent truth: no research funds
The Telegraph, 1 month ago
|
Novartis India fixes book closure for dividend AGMThe Register of Members Share Transfer Books of Novartis India will remain closed from July 18, 2013 to July 25, 2013 (both days inclusive) for the purpose of Payment of Dividend Annual General Meeting (AGM) of the Company to be held on July 25, 2013. Money Control, 1 week ago
The rise and rise of MNC R [Financial Express (India)]
TMC Net, 1 week ago
NPPA denies price hike to Sanofi, Novartis, Allergan
Smart Investor, 2 weeks ago
India wants EU to stop seizure of generic drugs [Financial Express (India)]
Pharmacy Choice, 2 weeks ago
More from: Frontier India, EIU...and 7 other sources
|
Intellectual Property Battles in Solid-State ChemistryThe rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms. Pharmaceutical Technology Volume 37, Issue 5, pp. 54-58 12 JASON ... Pharmaceutical Technology, 1 week ago
What future for branded drugs in India?
Manufacturing Chemist, 1 week ago
Indian Patents Act: Incentivising Innovation without compromising affordable healthcare
Bar & Bench, 1 week ago
India - Supreme Court rules in Novartis case
Managing IP, 3 weeks ago
|
Citigroup Capital Markets appointed as sole broker for sale of shares in Novartis India LtdNovartis India Ltd has announced with reference to the proposed reduction of promoter's shareholding in the Company through the Stock Exchange mechanism, Further, that the Company's promoter company, Novartis AG has informed to Company that they ... Equity Bulls, 1 week ago
Novartis AG appoints Citigroup as sole broker for share sale in Indian entity
Myiris, 2 weeks ago
Novartis appoints Citigroup as broker for Indian co share sale
Business Standard, 2 weeks ago
Novartis' Swiss promoter to reduce stake to meet public shareholding norms
Indian-Commodity, 1 week ago
|
Stocks in news: Suzlon, Berger Paints, Lupin, LTStocks in news: Suzlon Energy | Berger Paints | Coal India | Sterlite Industries | Lupin | LT | Novartis India | ICICI Bank | ONGC | GMM Pfaudler and BHEL are stocks| which are in news today. Money Control, 1 month ago
Now trending: MNCs up holdings in Indian units
Financial Chronicle, 3 weeks ago
Indian Shares Rally On RBI Rate Cut Talk
RTTNews.com, 1 week ago
Hold Novartis India till Rs 625: Tulsian
Money Control, 1 month ago
More from: , First Post.com...and 3 other sources
|
Novartis India quarterly net profit plunges 26%, sets dividend at Rs 10Net sales of the company for the full fiscal rose to Rs Financial Express, 1 week ago
|
Novartis Biotechnology Leadership Camp to be held in HyderabadThree winning students from India to participate in the International Novartis Biotechnology Leadership Camp at Basel, Switzerland The next edition of the Novartis Biotechnology Leadership Camp (BioCamp) will be held in Hyderabad from July 8 to 10, ... Express Pharma, 1 week ago
3 students to represent India at Novartis biotech camp in Switzerland
Business Line, 1 week ago
|
Novartis case: India to revoke drug patents in case of pandemicsCommerce and Industry Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis. First Post.com, 1 month ago
India must protect access to medicine
Livemint.com, 2 weeks ago
In the pharmacy of the world
Hindu Business Line, 3 weeks ago
Another India-EU meet in June to thrash out irritants
Economic Times, 1 month ago
More from: , Business Standard...and 6 other sources
|